News
China Medical University Hospital (Taiwan) and Shine-On Biomedical Co. developed SOB100, the world's first HLA-G targeted ...
Last Thursday during a roundtable on stem cell therapies, new FDA Commissioner Marty Makary referred to EBM levels of evidence as an artificial and dogmatic construct. Apparently Dr. David Katz's "mor ...
“We are going to wipe out the illicit vapes off the market,” said Department of Health and Human Services Secretary Robert F.
The FDA said the findings raise doubts about the reliability and viability of premarket submissions based on the company’s ...
Trump's decision to impose steep tariffs on China, now at 30% after peaking at 145% in April, as well as blockbuster seizures ...
FOX News on MSN1d
FDA to review baby formula for first time in nearly 30 yearsFox News senior medical analyst Dr. Marc Siegel discusses baby formula nutrition, rising measles cases and more on ‘Fox News ...
FDA Commissioner Dr. Marty Makary discusses baby formula nutrition and broader efforts to ‘make America healthy again’ on ...
7d
Pharmaceutical Technology on MSNZymeworks’ zanidatamab gains approval in China for biliary tract cancerChina’s National Medical Products Administration (NMPA) has conditionally approved Zymeworks’ zanidatamab for biliary tract ...
Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...
HHS Secretary RFK Jr. announces plans to fast-track rare disease drugs via streamlined FDA regulations. Read more here.
The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results